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In 6-hydroxy-D-nicotine oxidase (6HDNO) FAD is covalently bound to His7i of the polypeptide chain by an Sa-(~~-~stidyl)-riboflavin li kage. 
The FAD-binding histidine was exchanged by site-directed mutagenesis to either a Cys- or Tyr-residue, two amino acids known to be involved 
in covalent binding of FAD in other enzymes, or to a Ser-residue. None of the amino acid replacements for His ‘i allowed covalent FAD incorpora- 
tion into the 6-HDNO polypeptide. Thus, the amino acid residues involved in covalent FAD-binding require a specific polypeptide surrounding 
in order for this modification to proceed and cannot be replaced with each other. Enzyme activity was completely abolished with Tyr in place 
of His”. 6-HDNO activity with non-covalently bound FAD was found with 6-HDNO-Cys and to a lesser extent also with 6-HDNO-Ser. However, 
the K,,, values for 6-HDNO-Cys and 6-HDNO-Ser were increased approximately 20-fold as compared to 6-HDNO-His. Both mutant enzymes, 
in contrast to the wild-type enzyme, needed additional FAD in the enzymatic assay (50 PM for 6-HDNO-Ser and 10 PM for 6-HDNO-Cys) for 
maximal enzyme activity. 
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1. INTRODUCTION 
The prosthetic group of about a dozen flavoenzymes 
is covalently linked to the side chain of a particular 
amino acid. Involved in the protein modification by 
FAD are the imidazole of histidine, the SH-group of 
cysteine and the hydroxy-group of tyrosine [I]. Among 
the enzymes exhibiting an 8a-(A$histidyl)-riboflavin 
linkage, the most common covalent modification by 
FAD, is 6-hydroxy-D-nicotine oxidase (B-HDNO; EC 
1.5.3.6) of ~~~~~o~~c~e~ oxidu~s 121. We showed 
recently that the covalent incorporation of FAD into 
the 6-HDNO poiypeptide requires the presence of 
specific effecters represented by phosphopyruvate, 
3-phosphoglycerate, glyceraldehyde-3-phosphate or 
glycerol-3-phosphate (G-3-P) [3]. Here we investigate 
how the replacement of the FAD-binding histidine in 
6-HDNO by other amino acids known to be modified 
by flavins affects covalent flavinylation of the 
6-HDNO polypeptide and enzyme activity. 
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Universitat Freiburg, Hermann-Herder-Str. 7, D-7800 Freiburg, 
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To this goal we replaced by site-directed mutagenesis 
the FAD-binding His7’ of the 6-HDNO polypeptide 
with the amino acids cysteine, tyrosine or serine. The 
effects of these amino acid replacements on FAD at- 
tachment and enzyme activity are presented in this 
communication. 
2. MATERIALS AND METHODS 
2. I. Bacterial strains, plasmids and growth conditions 
E. coli strain JMI09 141 was used as host for the expression plasmid 
pDB222 151. In vivo labeling with [‘4C]FAD of the 6-HDNO polypep- 
tide in the E. coli RR28rf strain transformed with plasmid DNA was 
as in 16). 
Preparation of cell extracts, enzyme measurements and transfor- 
mation of 6-HDNO apoenzyme into holoenzyme were as described 
previously [6]. 
Polyacrylamide gel electrophoresis (PAGE) was according to 
Laemmli [7] and Western blots were reacted with 6-HDNO-specific 
antiserum and stained with horseradish peroxidase conjugated se- 
cond antibody as described by the manufacturer (Bio-Rad, Munich). 
2.2. Site-directed mutagenesis 
Site-directed mutagenesis was carried out according to Kunkel [S]. 
OIigonucleotides were synthesized with the aid of an automated 
nucleotide synthesizer by Dr Igloi (Institut fiir Biologic II, Freiburg, 
FRG). Verification of the introduced mutations was by DNA sequen- 
cing according to the dideoxynucleotide chain termination method 
]91. 
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CGA KC GGT GGC CAC AAT CCG AAT GGC 
pDfI222-wild-type 
Arg Ser Gly Gly HIS Asn Pro Asn Gly 
CGA TCC GGT GGC ;$C AAT CCG AAT GGC 
NlB222-CYS 
CYS 
CGA TCC GGT GGC i$C AAT CCG AAT GGC 
Ser 
CGA TCC GGT GGC iA,C AAT CCG AAT GGC 
Tyr 
pDB222-Ser 
pDB222-Tyr 
Fig.1. Site-directed mutagenesis of the FAD-binding His” of 
6-HDNO. Shown is the wild-type sequence surrounding the His”. 
Mutagenic oligonucleotides were derived according to this sequence 
with the nucleotide exchanges and the resulting amino acid 
replacements as indicated. 
3. RESULTS AND DISCUSSION 
3.1. Site-directed mutagenesis of the FAD-binding 
histidine residue 
The wild-type sequence containing the FAD-binding 
His’l and the oligonucleotides used for introduction of 
the mutations to serine, tyrosine and cysteine are 
presented in fig. 1. After reconstitution of the 6-HDNO 
gene in pDB222, these constructs were designed 
pDB222-Ser, pDB222-Cys and pDB222-Tyr. 
3.2. Enzyme activity of the mutant 6-HDNO poly- 
peptides 
In E. coli cells expressing 6-HDNO from recombi- 
nant plasmids, 6-HDNO activity in cell extracts can be 
increased by incubation with FAD and G-3-P. This in- 
crease in enzyme activity reflects the effector- 
dependent covalent incorporation of FAD into the 
apoenzyme [6]. For this reason 6-HDNO activity in ex- 
tracts prepared from E. coli cells carrying different 
plasmids was measured before and after incubation 
with FAD and G-3-P. The observed results are 
presented in table 1. The assay for 6-HDNO activity 
was performed in 1 ml of 0.1 M glycine buffer, pH 9.0, 
0.1 M NaCl and 0.5 PM 6-hydroxy-D-nicotine as 
substrate. Under these conditions, besides the wild-type 
enzyme, only the histidine to cysteine mutation ex- 
hibited enzyme activity. Incubation with FAD and 
Table 1 
Specific enzyme activity of wild-type and mutant enzymes expressed 
from recombinant plasmids in E. coli JM109 cells 
Plasmids and 
phenotypes 
6-HDNO activity 6-HDNO activity 
(nM.s-‘.mg-r) (nM.s-‘.mg-‘) + 
FAD/G-3-P 
pDB222.His (wild-type) 
pDB222.Cys 
pDB222Ser 
pDB222.Tyr 
1.1 2.2 
0.67 0.67 
nm nm 
nm nm 
Enzyme activities were determined under assay conditions used for 
the wild-type enzyme (0.5 mM 6-hydroxynicotine and no FAD) [2]. 
nm, not measurable 
a b 
6-HDNO_, I.” 
Fig.2. Expression of wild-type and mutated 6-HDNO in E. coli 
RR28rf cells. E. coli RR28rf cells transformed with plasmids carrying 
the wild-type or mutated 6-HDNO genes were grown in the presence 
of [“%]riboflavin and cell extracts were analyzed for proteins with 
covalently incorporated flavins on SDS-PAGE followed by 
fluorography (a) and for 6-HDNO-synthesis by immunostaining of 
Western blots with 6-HDNO-specific antibody (b). (a) Extract from 
cells expressing (lanes): 6-HDNO-His (l), 6-HDNO-Cys (2). 
6-HDNO-Ser (3), 6-HDNO-Tyr (4). Fp-SDH, flavoprotein subunit of 
succinate dehydrogenase; 6-HDNO, position of covalently 14C- 
labeled 6-HDNO polypeptide. (b) 6-HDNO antiserum-mediated 
staining of polypeptides corresponding to 6-HDNO-His (l), 
6-HDNO-Cys (2), 6-HDNO-Ser (3), and 6-HDNO-Tyr (4). 
G-3-P had no effect on the activity of the altered 
enzymes. 
3.3. f4C]FAD incorporation into the 6-HDNO poly- 
peptides 
Cell extracts from RR28rf cells grown in the presence 
of [‘4C]riboflavin and expressing the wild-type and the 
mutant 6-HDNO genes were analyzed by SDS-PAGE 
for covalent FAD incorporation into the 6-HDNO 
polypeptide. The results of these experiments are 
presented in fig.2a. 
One labeled polypeptide found in all cell extracts 
probably represents the flavoprotein subunit of suc- 
cinate dehydrogenase [lo]. A second labeled polypep- 
tide representing 6-HDNO is found only in cell extracts 
derived from cells expressing wild-type enzyme. It is ab- 
sent from extracts derived from cells expressing altered 
6-HDNO. Thus, only the 6-HDNO polypeptide with 
His” binds FAD covalently. The enzyme activity 
observed with 6-HDNO-Cys must therefore be ac- 
complished with non-covalently bound FAD. Incuba- 
tion of cell extracts containing the Ser-, Tyr- or 
Cys-6-HDNO polypeptide with [14C]FAD and G-3-P 
did not result in covalent incorporation of the cofactor 
(not shown) in contrast to what is found with the 
6-HDNO-His polypeptide [6]. 
The inability to detect covalently [14C]FAD-labeled, 
altered 6-HDNO polypeptides did not result from an 
impaired biosynthesis of these proteins. Analysis of ex- 
tracts from E. coli cells expressing wild-type and mu- 
tant polypeptides on Western blots by immunostaining 
with 6-HDNO-specific antibody revealed approximate- 
ly equal amounts of each protein (fig.2b). 
3.4. FAD dependence of 6-HDNO activity of altered 
enzymes 
6-HDNO activity measured with cell extracts con- 
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Fig.3. Time course of the 6-HDNO reaction performed with wild- 
type and mutant enzymes. 6-HDNO assays were performed as 
described in section 2. (A) Wild-type enzyme; (B) 6-HDNO-Cys, a, 
without addition of FAD, b, at 20rM FAD; (C) 6-HDNO-Ser, a, 
without addition of FAD, b, at 5OpM FAD. 
taining 6-HDNO-Cys or 6-HDNO-Ser and not sup- 
plemented with external FAD quickly plateaued (fig.3). 
With the altered enzymes an increase in [FAD] in the 
6-HDNO assay increased the length of time during 
which enzyme activity could be measured (fig.3). That 
is, the period of linear increase in absorption at 
334 nm, corresponding to the formation of the reaction 
product, was prolonged. This effect was not due to 
covalent FAD incorporation into the altered 6-HDNO 
polypeptide at the higher [FAD] nor was the effect 
observed with wild-type enzyme (not shown). Increased 
[FAD] in the reaction assay had, however, no signifi- 
cant effect on the reaction rate. This was a surprising 
finding, since we expected the altered enzymes to show 
perhaps a decreased affinity for FAD. In that case they 
would require higher [FAD] for saturation and full en- 
zyme activity. That was, however, not the case. If the 
cofactor was only loosely associated with the mutant 
6-HDNO polypeptides, it should have been possible to 
remove it by dialysis. When cell extracts containing 
6-HDNO-Ser or 6-HDNO-Cys were extensively dialyz- 
ed against 100 mM phosphate buffer, pH 7.0, no 
decrease in the initially observed specific 6-HDNO ac- 
tivity was found. At 10 PM FAD final concentration in 
the reaction assays the 6-HDNO-Cys worked best. 
6-HDNO-Ser required 50 FM FAD for optimal activi- 
ty. Efforts are currently being made to elucidate the 
[FAD] effect on 6-HDNO-Cys and 6-HDNO-Ser activi- 
ty by isolating the corresponding polypeptides. 
From our results we may conclude the following. (i) 
Replacement of His7r with Cys, Ser or Tyr abolishes 
covalent binding of FAD to the apoenzyme. The amino 
acids Cys and Tyr used to replace His7’ are involved in 
covalent binding of FAD in other enzymes. Thus, the 
specific features of the apo-6-HDNO polypeptide per- 
mit the establishment of a covalent bond to FAD only 
with the imidazole ring of histidine. (ii) Mutant 
6-HDNOs with non-covalently bound FAD show en- 
zyme activity. The extent of enzyme activity is depen- 
dent on the amino acid replacing His71. 6-HDNO-Cys 
comes closest o the wild-type enzyme, whereas replace- 
ment of histidine with tyrosine abolishes enzyme activi- 
ty. (iii) In contrast to the wild-type enzyme where 
covalent binding of FAD, and thus enzyme activity, 
can be modulated by effector molecules [6], no effect 
of these molecules on FAD-incorporation and enzyme 
activity of the altered 6-HDNO polypeptides was 
found. 
Recently, similar results were presented in a short 
report on the site-directed mutagenesis of the FAD- 
binding histidine of fumarate reductase [l 11. 
Acknowledgements: We wish to thank Professor K. Decker for 
valuable suggestions and comments regarding this work, Dr P. 
Nielsen for help with the site-directed mutagenesis and H. Gottschalk 
for her help with the preparation of this manuscript. This work was 
supported by a grant from the DFG through SFB 206. 
REFERENCES 
111 
121 
131 
141 
(51 
WI 
171 
PI 
PI 
[lOI 
1111 
Singer, T. and McIntire, W.S. (1984) Methods Enzymol. 106, 
369-378. 
Mohler, H., Briihmtiller, M. and Decker, K. (1972) Eur. J. Bio- 
them. 29, 152-155. 
Brandsch, R. and Bichler, V. (1987) FEBS Lett. 224, 121-124. 
Yanisch-Perron, C., Vieira, J. and Messing, J. (1985) Gene 33, 
103-119. 
Brandsch, R., Bichler, V. and Nagursky, H. (1987) Eur. J. Bio- 
them. 165, 559-564. 
Brandsch, R. and Bichler, V. (1989) Eur. J. Biochem. 182, 
125-128. 
Laemmli, U.K. (1970) Nature (Lond.) 227, 680-685. 
Kunkel, T. (1985) Proc. Natl. Acad. Sci. USA 82, 488-492. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) Proc. Natl. 
Acad. Sci. USA 74, 5463-5467. 
Hederstedt, L. (1983) Eur. J. Biochem. 132, 589-593. 
Cecchini, G., Ackrell, B.A.C., Whittiker, K., Blant, M. and 
Gunsalus, R.P. (1988) FASEB J. 2, 354. 
88 
